Location: New York, NY
CIK: 0001831942 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $1.502B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RLAY | RELAY THERAPEUTICS INC | 17,000,000 | $144M | 9.6% | $3.15 | +126.2% | COM | 75943R102 |
| ALKS | ALKERMES PLC | 3,550,000 | $99.33M | 6.6% | $27.24 | +9.9% | SHS | G01767105 |
| TYRA | TYRA BIOSCIENCES INC | 3,375,000 | $88.73M | 5.9% | $10.62 | +72.9% | COM | 90240B106 |
| XENE | XENON PHARMACEUTICALS INC | 1,800,000 | $80.68M | 5.4% | $30.82 | +36.3% | COM | 98420N105 |
| SYRE | SPYRE THERAPEUTICS INC | 2,388,245 | $78.24M | 5.2% | $16.69 | +56.6% | COM NEW | 00773J202 |
| COGT | COGENT BIOSCIENCES INC | 2,196,845 | $78.03M | 5.2% | $10.67 | +163.6% | COM | 19240Q201 |
| ELVN | ENLIVEN THERAPEUTICS INC | 4,692,809 | $72.27M | 4.8% | $19.08 | +4.4% | COM | 29337E102 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2,565,000 | $69.67M | 4.6% | $22.13 | +19.0% | COM NEW | 15117B202 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 5,650,000 | $68.25M | 4.5% | $10.57 | +28.4% | COM | 03237H101 |
| TERN | TERNS PHARMACEUTICALS INC | 1,475,000 | $59.59M | 4.0% | $6.39 | +261.9% | COM | 880881107 |
| KYMR | KYMERA THERAPEUTICS INC | 750,000 | $58.36M | 3.9% | $34.43 | +96.1% | COM | 501575104 |
| SLNO | SOLENO THERAPEUTICS INC | 1,200,000 | $55.56M | 3.7% | $58.91 | -6.9% | COM | 834203309 |
| NUVL | NUVALENT INC | 550,000 | $55.32M | 3.7% | $67.32 | +46.5% | COM | 670703107 |
| ORKA | ORUKA THERAPEUTICS INC | 1,753,054 | $53.14M | 3.5% | $30.70 | -9.2% | COM | 687604108 |
| PHVS | PHARVARIS N V | 1,889,445 | $52.43M | 3.5% | $22.98 | +4.8% | COM | N69605108 |
| NRIX | NURIX THERAPEUTICS INC | 2,275,000 | $43.16M | 2.9% | $21.29 | -32.5% | COM | 67080M103 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 450,000 | $39.3M | 2.6% | $47.99 | +70.5% | COM | 74366E102 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 1,000,000 | $34.01M | 2.3% | $21.94 | +46.8% | COM NEW | 045396207 |
| LBRX | LB PHARMACEUTICALS INC | 1,500,000 | $33.39M | 2.2% | $15.87 | +10.1% | COM SHS | 50180M108 |
| CTMX | CYTOMX THERAPEUTICS INC | 7,692,300 | $32.77M | 2.2% | $1.61 | +135.7% | COM | 23284F105 |
| ANRO | ALTO NEUROSCIENCE INC | 1,823,196 | $32.45M | 2.2% | $12.59 | 0.0% | COM SHS | 02157Q109 |
| PALI | PALISADE BIO INC | 11,445,000 | $26.9M | 1.8% | $1.92 | 0.0% | COM | 696389402 |
| — | MIND MEDICINE MINDMED INC | 2,000,000 | $26.78M | 1.8% | $8.32 | — | COM NEW | 60255C885 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,000,000 | $25.01M | 1.7% | $15.31 | — | SPONSORED ADS | 152309100 |
| PEPG | PEPGEN INC | 3,400,000 | $22.13M | 1.5% | $2.71 | +91.6% | COM | 713317105 |
| SABS | SAB BIOTHERAPEUTICS INC | 4,401,500 | $16.46M | 1.1% | $2.26 | +45.5% | COM NEW | 78397T202 |
| REPL | REPLIMUNE GROUP INC | 1,425,000 | $13.85M | 0.9% | $8.50 | 0.0% | COM | 76029N106 |
| IKT | INHIBIKASE THERAPEUTICS INC | 5,397,488 | $11.06M | 0.7% | $2.49 | -36.2% | COM NEW | 45719W205 |
| CTNM | CONTINEUM THERAPEUTICS INC | 816,326 | $9.331M | 0.6% | $11.41 | 0.0% | CL A | 21217B100 |
| AVTX | AVALO THERAPEUTICS INC | 483,000 | $8.771M | 0.6% | $10.53 | +60.3% | COM NEW | 05338F306 |
| RAPT | RAPT THERAPEUTICS INC | 250,000 | $8.467M | 0.6% | $31.06 | 0.0% | COM NEW | 75382E208 |
| LONA | ATHIRA PHARMA INC | 464,398 | $3.515M | 0.2% | $4.58 | 0.0% | COM | 04746L203 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 18,851 | $1.471M | 0.1% | $35.19 | +89.9% | COM NEW | 10919W405 |